Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.

Peter A LioApril ArmstrongJan GutermuthAudrey NosbaumHoward SofenEsther Garcia GilMarta CasillasSherry ChenLuna SunEvangeline PierceHany ElmaraghyZach DawsonTiago Torres

Published in: Dermatology and therapy (2024)

ClinicalTrials.gov Registration NCT04146363 (ADvocate1) and NCT04178967 (ADvocate2).

Keyphrases

patient reported
atopic dermatitis
high intensity
early onset